Bergman A, Karram M M, Bhatia N N
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
Gynecol Obstet Invest. 1990;29(3):211-3. doi: 10.1159/000293384.
Estrogen vaginal cream was given to 10 postmenopausal women with a diagnosis of genuine stress urinary incontinence. Clinical evaluation and urethral cytology from the midurethra were performed before and after 6 weeks of estrogen treatment. A favorable clinical response was obtained in 50% of the treated patients, in whom signs and symptoms of incontinence disappeared or significantly improved, by subjective and objective evaluation. Cytologic changes at the midurethra correlated well with clinical response to estrogens. Patients with a favorable response to treatment showed a positive 'maturation index' of squamous epithelium, changing towards more intermediate and superficial cells, and less transitional cells (p less than 0.05). Patients with a poor clinical response to estrogens had no significant change in urethral cytology after 6 weeks of therapy. Our results suggest that improvement or cure of stress incontinence after estrogen administration in postmenopausal women is achieved by affecting the 'urethral mucosal factor'.
对10名诊断为真性压力性尿失禁的绝经后女性给予雌激素阴道乳膏。在雌激素治疗6周前后进行临床评估和尿道中段细胞学检查。通过主观和客观评估,50%的治疗患者获得了良好的临床反应,其失禁的体征和症状消失或显著改善。尿道中段的细胞学变化与对雌激素的临床反应密切相关。对治疗反应良好的患者鳞状上皮“成熟指数”呈阳性,向更多中层和表层细胞转变,而移行细胞减少(p<0.05)。对雌激素临床反应不佳的患者在治疗6周后尿道细胞学无明显变化。我们的结果表明,绝经后女性服用雌激素后压力性尿失禁的改善或治愈是通过影响“尿道黏膜因素”实现的。